Common Cold Clinical Trial
Official title:
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
The study is designed to assess the effect of ingestion of a probiotic on innate and adaptive host responses to rhinovirus infection.
The common cold is a ubiquitous illness of man that is associated with significant medical
and socioeconomic consequences. Current treatments for the common cold that have proven
efficacy are limited to pharmacologic agents that are directed at specific symptoms. These
treatments- antihistamines, nasal decongestants and analgesics- have limited effectiveness,
generally relieving the target symptom by 15-25% at the peak of activity, and are associated
with bothersome side effects. There are no currently effective treatments for prevention of
rhinovirus infections.
Probiotics have been defined by FAO/WHO as "Live microorganisms which when administered in
adequate amount confer a health benefit on a host." The most common probiotics belong to
Lactobacillus or Bifidobacterium genera. Bifidobacteria are natural human gut inhabitants
that were discovered over a hundred years ago from the feces of breast-fed infants. The
study product Bifidobacterium animalis subspecies (subsp.) lactis Bl-04 (Bl-04) has been
genetically characterized as B. animalis subsp. lactis by 16S rRNA gene sequencing and full
genome sequence comparison. Bl-04 has been deposited in the American Type Culture
Collections safe deposit as SD5219.
This study will test the hypothesis that ingestion of a probiotic Bifidobacterium animalis
subsp. lactis Bl-04 will alter the innate and adaptive host response to rhinovirus
infection.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05269290 -
Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections
|
Phase 3 | |
| Completed |
NCT02451163 -
DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly
|
Phase 2 | |
| Completed |
NCT01944631 -
Iota-Carrageenan Nasal Spray in Common Cold
|
Phase 4 | |
| Completed |
NCT01651715 -
Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections
|
Phase 1/Phase 2 | |
| Completed |
NCT00963443 -
Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold
|
Phase 3 | |
| Completed |
NCT00778648 -
Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms
|
N/A | |
| Completed |
NCT00065715 -
Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)
|
Phase 3 | |
| Completed |
NCT00032500 -
Evaluation of Echinacea for the Common Cold
|
Phase 2 | |
| Not yet recruiting |
NCT05070650 -
Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold
|
Phase 3 | |
| Completed |
NCT04144491 -
Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda
|
N/A | |
| Not yet recruiting |
NCT04073511 -
Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold
|
N/A | |
| Completed |
NCT03189537 -
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
|
Phase 3 | |
| Terminated |
NCT01964885 -
Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections
|
Phase 3 | |
| Completed |
NCT01277081 -
Effect of Paracetamol on the Common Cold
|
Phase 2 | |
| Completed |
NCT01728090 -
Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections
|
Phase 4 | |
| Completed |
NCT00405509 -
The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years
|
N/A | |
| Completed |
NCT01033526 -
Symptomatic Treatment of Common Cold Symptoms
|
Phase 4 | |
| Completed |
NCT05556148 -
Otrivine: Quality of Life (QoL) Impact in a Real-World Setting
|
Phase 4 | |
| Terminated |
NCT03339726 -
Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold
|
Phase 2 | |
| Completed |
NCT01361399 -
Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold
|
Phase 3 |